Fritextsökning
Artiklar per år
-
Biosensor vill genomföra emissioner
Ägarna kallas till extrastämma om två veckor för att ta ställning till styrelsens förslag.
-
Lunds nya rektor har tillträtt
Nu är han på plats. Vinnovas förre generaldirektör tar över rodret vid Lunds universitet.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.
-
Sales Representative, Applied Biosystems
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.